IL150430A0 - Cell division inhibitors and process for producing the same - Google Patents

Cell division inhibitors and process for producing the same

Info

Publication number
IL150430A0
IL150430A0 IL15043000A IL15043000A IL150430A0 IL 150430 A0 IL150430 A0 IL 150430A0 IL 15043000 A IL15043000 A IL 15043000A IL 15043000 A IL15043000 A IL 15043000A IL 150430 A0 IL150430 A0 IL 150430A0
Authority
IL
Israel
Prior art keywords
producing
same
cell division
division inhibitors
inhibitors
Prior art date
Application number
IL15043000A
Other languages
English (en)
Original Assignee
Nereus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nereus Pharmaceuticals Inc filed Critical Nereus Pharmaceuticals Inc
Publication of IL150430A0 publication Critical patent/IL150430A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15043000A 2000-01-18 2000-09-29 Cell division inhibitors and process for producing the same IL150430A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000009370 2000-01-18
PCT/JP2000/006807 WO2001053290A1 (fr) 2000-01-18 2000-09-29 Inhibiteurs de la division cellulaire et procede de production de ces inhibiteurs

Publications (1)

Publication Number Publication Date
IL150430A0 true IL150430A0 (en) 2002-12-01

Family

ID=18537534

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15043000A IL150430A0 (en) 2000-01-18 2000-09-29 Cell division inhibitors and process for producing the same
IL150430A IL150430A (en) 2000-01-18 2002-06-26 Cell division inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150430A IL150430A (en) 2000-01-18 2002-06-26 Cell division inhibitors

Country Status (12)

Country Link
US (2) US6972289B1 (xx)
EP (1) EP1264831A4 (xx)
JP (1) JP4810043B2 (xx)
KR (1) KR100831400B1 (xx)
AU (2) AU782917C (xx)
BR (2) BR0017067A (xx)
CA (1) CA2403790C (xx)
IL (2) IL150430A0 (xx)
MX (1) MXPA02006826A (xx)
NZ (1) NZ519989A (xx)
WO (1) WO2001053290A1 (xx)
ZA (1) ZA200206576B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2240118C (en) 1997-06-09 2005-11-22 Hitachi Ltd. Image sequence coding method and decoding method
US7026322B2 (en) * 1998-11-12 2006-04-11 Nereus Pharmaceuticals, Inc. Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
IL150430A0 (en) * 2000-01-18 2002-12-01 Nereus Pharmaceuticals Inc Cell division inhibitors and process for producing the same
CN101633655B (zh) * 2002-08-02 2014-04-30 大连万春药业有限公司 脱氢苯基阿夕斯丁及其类似物以及脱氢苯基阿夕斯丁及其类似物的合成
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
CN100540548C (zh) * 2002-08-02 2009-09-16 尼瑞斯药品公司 脱氢苯基阿夕斯丁及其类似物以及脱氢苯基阿夕斯丁及其类似物的合成
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
RU2005119172A (ru) * 2002-12-18 2006-01-20 Пфайзер Продактс Инк. (Us) Производные 4-анилинхиназолина для лечения патологического роста клеток
GR1004602B (el) 2003-07-03 2004-06-18 Μεθοδοι παρασκευης παραγωγων δεϋδρο-δικετοπιπεραζινων
EP1711487A1 (en) * 2004-02-04 2006-10-18 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
CN1934101B (zh) * 2004-02-04 2011-10-12 尼瑞斯药品公司 脱氢苯基阿夕斯丁及其类似物以及脱氢苯基阿夕斯丁及其类似物的合成
US7732605B2 (en) * 2005-03-29 2010-06-08 Nereus Pharmaceuticals, Inc. Synthesis of diketopiperazines
AR058408A1 (es) 2006-01-02 2008-01-30 Basf Ag Compuestos de piperazina con accion herbicida
PE20071051A1 (es) * 2006-01-05 2007-11-29 Basf Ag Compuestos de piperazina con accion herbicida
US8129527B2 (en) * 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
PE20090334A1 (es) * 2007-06-12 2009-04-26 Basf Se Compuestos de piperazina con accion herbicida
WO2008152074A1 (de) * 2007-06-12 2008-12-18 Basf Se Herbizid wirksame zusammensetzung
WO2008152073A2 (de) * 2007-06-12 2008-12-18 Basf Se Piperazinverbindungen mit herbizider wirkung
US20110130286A1 (en) * 2008-07-29 2011-06-02 Basf Se Piperazine Compounds with Herbicidal Effect
JP2011530559A (ja) * 2008-08-13 2011-12-22 ビーエーエスエフ ソシエタス・ヨーロピア ピペラジンジオン誘導体を調製する方法
WO2010037727A1 (de) * 2008-10-02 2010-04-08 Basf Se Piperazinverbindungen mit herbizider wirkung
JP6904570B2 (ja) 2015-03-06 2021-07-21 ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド 脳腫瘍の治療方法
CN107530341B (zh) 2015-03-06 2021-10-01 大连万春布林医药有限公司 治疗与ras突变相关的癌症的方法
BR112018000229A2 (pt) 2015-07-13 2018-09-04 Beyondspring Pharmaceuticals Inc composições de plinabulina
SG11201806583XA (en) 2016-02-08 2018-09-27 Beyondspring Pharmaceuticals Inc Compositions containing tucaresol or its analogs
AU2017278245B2 (en) 2016-06-06 2022-09-15 Beyondspring Pharmaceuticals, Inc. Composition and method for reducing neutropenia
EP4089085B1 (en) 2016-08-12 2024-04-03 Shenzhen Huahong Marine Biomedicine Co., Ltd Manufacturing and purification method of polycrystalline form of dehydrophenylahistin-like compound
CN106565686B (zh) * 2016-10-11 2019-03-01 深圳海王医药科技研究院有限公司 微管蛋白抑制剂
CN110431135A (zh) 2017-01-06 2019-11-08 大连万春布林医药有限公司 微管蛋白结合化合物及其治疗用途
KR20190109479A (ko) 2017-02-01 2019-09-25 비욘드스프링 파마수티컬스, 인코포레이티드. 호중구감소증의 감소 방법
JP7350015B2 (ja) 2018-01-24 2023-09-25 ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド プリナブリンの投与による血小板減少症を軽減するための組成物および方法
KR20220117501A (ko) 2021-02-17 2022-08-24 주식회사 티제이 카드리더기 모듈의 슬림화장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725858A (ja) * 1993-07-13 1995-01-27 Otsuka Pharmaceut Co Ltd ピペラジン誘導体
GB9402809D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9426224D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
JP3131574B2 (ja) * 1996-09-04 2001-02-05 新日本製鐵株式会社 新規抗腫瘍物質、該物質を製造するための微生物及び方法、並びに該物質を有効成分とする細胞周期阻害剤及び抗腫瘍剤
US6069146A (en) * 1998-03-25 2000-05-30 The Regents Of The University Of California Halimide, a cytotoxic marine natural product, and derivatives thereof
US6358957B1 (en) * 1998-11-12 2002-03-19 Nereus Pharmaceuticals, Inc. Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
IL150430A0 (en) * 2000-01-18 2002-12-01 Nereus Pharmaceuticals Inc Cell division inhibitors and process for producing the same
US7919497B2 (en) * 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN100540548C (zh) * 2002-08-02 2009-09-16 尼瑞斯药品公司 脱氢苯基阿夕斯丁及其类似物以及脱氢苯基阿夕斯丁及其类似物的合成

Also Published As

Publication number Publication date
JP4810043B2 (ja) 2011-11-09
CA2403790A1 (en) 2001-07-26
BR0017067A (pt) 2002-10-22
AU782917B2 (en) 2005-09-08
AU782917C (en) 2006-11-23
WO2001053290A1 (fr) 2001-07-26
EP1264831A1 (en) 2002-12-11
AU2005242133A1 (en) 2006-01-05
AU7451100A (en) 2001-07-31
US6972289B1 (en) 2005-12-06
NZ519989A (en) 2004-05-28
US20060079534A1 (en) 2006-04-13
EP1264831A4 (en) 2005-11-23
KR20020082484A (ko) 2002-10-31
CA2403790C (en) 2011-09-27
MXPA02006826A (es) 2004-04-05
BRPI0017067B1 (pt) 2019-08-27
ZA200206576B (en) 2003-05-12
BRPI0017067B8 (pt) 2021-05-25
IL150430A (en) 2011-03-31
KR100831400B1 (ko) 2008-05-21
AU2005242133B2 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
IL150430A0 (en) Cell division inhibitors and process for producing the same
EP1270717A4 (en) CHLAMYDOSPORES AND METHOD FOR THE PRODUCTION THEREOF
AU7886301A (en) Transesterification process
GB0011120D0 (en) Process
GB2381537B (en) High-cleanliness steel and process for producing the same
AU8968101A (en) Electrochemical element and process for its production
GB0023781D0 (en) Process
GB0020523D0 (en) Process
GB0013793D0 (en) Process
EP1277590A4 (en) RECORD SHEET AND ITS MANUFACTURING METHOD
GB0010437D0 (en) Process
GB0020021D0 (en) Process
GB0002201D0 (en) Process
EP1146054A4 (en) RE1A BINDING INHIBITOR, METHOD FOR THE PRODUCTION THEREOF, AND USE OF SAID BINDING INHIBITOR
GB0014583D0 (en) Process
GB2410252B (en) High-cleanliness steel and process for producing the same
GB0013791D0 (en) Process
GB0013817D0 (en) Method for treating cells
GB0016633D0 (en) Process
GB2406580B (en) High-cleanliness steel and process for producing the same
GB0001564D0 (en) Process
GB0006722D0 (en) Process
GB0000935D0 (en) Process
GB0009709D0 (en) Process
GB0007517D0 (en) Process

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed